Revance Therapeutics, Inc., a clinical stage biotechnology company based in Nashville, Tennessee, specializes in developing and commercializing novel botulinum toxin products for both aesthetic and therapeutic uses. The company, which went public in 2014, offers products like DAXXIFY for aesthetic improvements and is exploring its use in treating muscle movement disorders such as cervical dystonia and upper limb spasticity.
RVNC filed a patent for "methods of treating or preventing migraine or repetitive occurrence of common migraine headaches in a subject having underlying condition(s)" on Wed, July 26, 2023. The patent was officially published on Thu, January 4, 2024.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
